Skip to main content
School of Pharmacy and Pharmaceutical Sciences


Gail B. Rattinger

Gail B. Rattinger, PharmD, PhD

Associate Dean for Academic Affairs and Assessment and Professor, Health Outcomes and Administrative Sciences
Phone: 607-777-5474
Office: Academic A, Room 104


Research focus
  • Health outcomes, neurodegenerative diseases
  • Pharmacoepidemiology
  • Large-claims databases
  • Bachelor of Arts, chemistry, Occidental College, Los Angeles
  • Doctor of Philosophy, physical inorganic chemistry, University of Illinois at Urbana-Champaign
  • Doctor of Pharmacy, University of California at San Francisco
  • Postdoctoral fellowship in pharmacoeconomics, pharmacoepidemiology and health outcomes, University of Maryland School of Pharmacy

A licensed pharmacist with a background in health services research, pharmacy education and academia, Gail B. Rattinger, PharmD, PhD, joins Binghamton University's School of Pharmacy and Pharmaceutical Sciences as associate dean for academic affairs and assessment and professor in the Health Outcomes and Administrative Sciences Department.

Prior to joining Binghamton, she was associate professor of pharmacy practice and pharmacy practice division director at the Fairleigh Dickinson University School of Pharmacy.

Rattinger brings experience in contemporary, forward-thinking curriculum and course development as well as assessment aimed at advancing the pharmacy profession. She is committed to employing active learning and assessment across Binghamton's pharmacy school curricula to ensure that curricular delivery prepares pharmacy students to assume significant “top-of license” roles on interprofessional healthcare teams as well as within research organizations.

Rattinger's funded research projects include studies of psychopharmaceutical use by dementia patients across care settings along with longitudinal models of their impact on cognitive and functional decline using large claims databases. Her research interests span the health and associated unmet needs of geriatric populations with a focus on neurodegenerative disease, particularly dementia and include longitudinal studies on factors associated with the informal costs of dementia care. Her publications provide valuable information for clinicians and decision-makers alike regarding the impact of medications on health outcomes as well as opportunities for disease management.

Last Updated: 9/18/17